Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
Research data
DOI
 |
Open Access Gold |
|
as soon as is submitted to ZB.
Modelling pancreatic beta-cell inflammation in zebrafish identifies the natural product wedelolactone for human islet protection.
Dis. Model. Mech. 12:dmm036004 (2019)
Islet inflammation and cytokine production are implicated in pancreatic beta-cell dysfunction and diabetes pathogenesis. However, we lack therapeutics to protect the insulin-producing beta-cells from inflammatory damage. Closing this clinical gap requires the establishment of new disease models of islet inflammation to facilitate screening efforts aimed at identifying new protective agents. Here, we have developed a genetic model of Interleukin-1 beta (Il-1 beta)-driven islet inflammation in zebrafish, a vertebrate that allows for non-invasive imaging of beta-cells and in vivo drug discovery. Live imaging of immune cells and beta-cells in our model revealed dynamic migration, increased visitation and prolonged macrophage retention in the islet, together with robust activation of NF-kappa B signalling in beta-cells. We find that Il-1 beta-mediated inflammation does not cause beta-cell destruction but, rather, it impairs beta-cell function and identity. In vivo, beta-cells exhibit impaired glucose-stimulated calcium influx and reduced expression of genes involved in function and maturity. These defects are accompanied by alpha-cell expansion, glucose intolerance and hyperglycemia following a glucose challenge. Notably, we show that a medicinal plant derivative (wedelolactone) is capable of reducing the immune-cell infiltration while also ameliorating the hyperglycemic phenotype of our model. Importantly, these anti-diabetic properties in zebrafish are predictive of wedelolactone's efficacy in protecting rodent and human islets fromcytokine-induced apoptosis. Insummary, this newzebrafish model of diabetes opens a window to study the interactions between immune and beta-cells in vivo, while also allowing the identification of therapeutic agents for protecting beta-cells from inflammation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.028
1.034
13
12
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Diabetes ; Inflammation ; Insulin ; Islet ; Regeneration ; Zebrafish ; Beta-cells; In-vivo; Receptors; Ablation; Targets; Interleukin-1; Inhibition; Insulitis; Blockade; Survival
Language
english
Publication Year
2019
HGF-reported in Year
2019
ISSN (print) / ISBN
1754-8403
e-ISSN
1754-8411
Journal
Disease Models and Mechanisms
Quellenangaben
Volume: 12,
Issue: 1,
Article Number: dmm036004
Publisher
Company of Biologists
Publishing Place
Bidder Building, Station Rd, Histon, Cambridge Cb24 9lf, England
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502600-010
WOS ID
WOS:000457419600003
Scopus ID
85060544348
Erfassungsdatum
2019-03-12